Palladium, chloro[(9,9-dimethyl-9H-xanthene-4,5-diyl)bis[diphenylphosphine-κP]](η3-2-propenyl)- CAS 879689-28-8
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 879689-28-8 |
| Molecular Formula | C42H37ClOP2Pd |
| Molecular Weight | 761.56 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Palladium, chloro[(9,9-dimethyl-9H-xanthene-4,5-diyl)bis[diphenylphosphine-κP]](η3-2-propenyl)- (CAS 879689-28-8), a pharmaceutical standards reference standard manufactured under ISO 17034 accreditation. Molecular formula: C42H37ClOP2Pd. Molecular weight: 761.56 g/mol. Batch-specific COA and technical support are available on request.
Physical & Chemical Properties
| Molecular Formula | C42H37ClOP2Pd |
| Molecular Weight | 761.56 g/mol |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 24.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1987 |
| Halogen Content | Cl-containing |
Related Palladium Standards
- Palladium, bis[1,3-bis(η2-ethenyl)-1,1,3,3-tetramethyldisiloxane][μ-(η2:η2-1,3-diethenyl-1,1,3,3-tetramethyldisiloxane)]di-, stereoisomer (CAS 252062-59-2)
- Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro[4,5-dihydro-2-(4-methoxyphenyl)oxazole-κN3]-, (SP-4-1)- (CAS 1586000-51-2)
- Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro[2-(4-fluorophenyl)-4,5-dihydrooxazole-κN3]-, (SP-4-1)- (CAS 1586000-52-3)
- Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro[4,5-dihydro-2-(4-methylphenyl)oxazole-κN3]-, (SP-4-1)- (CAS 1586000-48-7)
- Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro[1-(phenylmethyl)-1H-imidazole-κN3]-, (SP-4-1)- (CAS 1537173-00-4)
- Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(4,5-dihydro-2-phenyloxazole-κN3)-, (SP-4-1)- (CAS 1586000-47-6)
- Palladium, [1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(1-phenyl-1H-imidazole-κN3)-, (SP-4-1)- (CAS 1537173-02-6)
- Palladium,[2'-(amino-κN)[1,1'-biphenyl]-2-yl-κC](tricyclohexylphosphine)(1,1,1-trifluoromethanesulfonato-κO)- (CAS 1507404-45-6)
Recommended Standards
- 5,10,15,20-Tetrakis-(4-aminophenyl)-porphyrin-Ni(II) (CAS 67595-99-7)
- Pomalidomide-PEG<SUB>6</SUB>-butyl iodide (CAS 1835705-74-2)
- Iobitridol Impurity 15 (CAS CATO-C4X-317815)
- 3-(((3,5-Dimethyl-4-nitro-1h-pyrazol-1-yl)methyl)thio)-5-(trifluoromethyl)-4h-1,2,4-triazol-4-amine (CAS 957005-96-8)
- (2S)-4-methyl-1-(pyrrolidin-1-yl)pentan-2-amine (CAS 943754-35-6)
- 1,3-Benzenedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, 2,5-furandione, hexanedioic acid, 1,3-isobenzofurandione and 1,2-propanediol (CAS 67859-36-3)
- 3-(3-(Benzo[d][1,3]dioxol-5-yloxy)-2-oxopyrrolidin-1-yl)benzoic acid (CAS 649773-85-3)
- 2-(1H-1,2,4-Triazol-5-yl)aniline (CAS 6219-58-5)
- 2-Methyloxazole-5-sulfonyl chloride (CAS 1909316-63-7)
- Fas C- Terminal Tripeptide (CAS 189109-90-8)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com